As shown in Fig. 6, under the effect of CCL20, a cognate ligand for CCR6, both LCL and DLBCL cells with higher expression levels of CCR6 (Fig. 6A) showed higher chemotactic migration ability than cell lines with lower CCR6 expression (Fig. 6B–H). This evidence concerns the gene CCL20 and diffuse large B-cell lymphoma.